Evidence map›Paper›PMID 40067411›Full record

ArticleInterdisciplinary sciences, computational life sciences2025

Advancing the Accuracy of Anti-MRSA Peptide Prediction Through Integrating Multi-Source Protein Language Models.

Watshara Shoombuatong, Pakpoom Mookdarsanit, Lawankorn Mookdarsanit, Nalini Schaduangrat, Saeed Ahmed, Muhammad Kabir, Pramote Chumnanpuen

Abstract read
PubMed Publisher
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Watshara ShoombuatongCenter for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok, 10700, Thailand. watshara.sho@mahidol.ac.th.ORCID https://orcid.org/0000-0002-3394-8709
Pakpoom MookdarsanitComputer Science and Artificial Intelligence, Faculty of Science, Chandrakasem Rajabhat University, Bangkok, 10900, Thailand.
Lawankorn MookdarsanitBusiness Information System, Faculty of Management Science, Chandrakasem Rajabhat University, Bangkok, 10900, Thailand.
Nalini SchaduangratCenter for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok, 10700, Thailand.
Saeed AhmedCenter for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok, 10700, Thailand.
Muhammad KabirSchool of Systems and Technology, University of Management and Technology, Lahore, 54782, Pakistan.
Pramote ChumnanpuenDepartment of Zoology, Faculty of Science, Kasetsart University, Bangkok, 10900, Thailand.

Funding

Mahidol University Partnering Initiative under the MU-KMUTT Biomedical Engineering & Biomaterials ConsortiumNational Research Council of Thailand and Mahidol University N42A660380
6 · The paper itself

Abstract

The emergence of methicillin-resistant Staphylococcus aureus (MRSA) as a recognized cause of community-acquired and hospital infections has brought about a need for the efficient and accurate identification of peptides with anti-MRSA properties in drug discovery and development pipelines. However, current experimental methods often tend to be labor- and resource-intensive. Thus, there is an immediate requirement to develop practical computational solutions for identifying sequence-based anti-MRSA peptides. Lately, pre-trained protein language models (pLMs) have emerged as a remarkable advancement for encoding peptide sequences as discriminative feature embeddings, uncovering plentiful protein-level information and successfully repurposing it for in silico peptide property prediction. In this study, we present pLM4MRSA, a framework based on pLMs designed to enhance the accuracy of predicting anti-MRSA peptides. In this framework, we combine feature embeddings from various pLMs, such as ProtTrans, and evolutionary-scale modeling (ESM-2) which provide complementary information for prediction. These individual pLM strengths are integrated to form hybrid feature embeddings. Next, we apply principal component analysis (PCA) to process these hybrid embeddings. The resulting PCA-transformed feature vectors are then used as inputs for constructing the predictive model. Experimental results on the independent test dataset showed that the proposed pLM4MRSA approach achieved a balanced accuracy and Matthew correlation coefficient of 0.983 and 0.980, respectively, representing remarkable improvements over the state-of-the-art methods by 2.53%-4.83% and 7.73%-13.23%, respectively. This indicates that pLM4MRSA is a high-performance prediction model with excellent scope of applicability. Additionally, comparison with well-known hand-crafted features demonstrated that the proposed hybrid feature embeddings complement each other effectively, capturing discriminative patterns for more accurate anti-MRSA peptide prediction. We anticipate that pLM4MRSA will serve as an effective solution for accurate and high-capacity prediction of anti-MRSA peptides from peptide sequences.

Indexed as

Anti-Bacterial AgentsComputational BiologyMethicillin-Resistant Staphylococcus aureusPeptidesPrincipal Component AnalysisAnti-Bacterial AgentsPeptidesAnti-MRSA peptideBioinformaticsEmbeddingMachine learningProtein language model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.